Ritu Roy

Title(s)PROGR ANL 3, HDF Comprehensive Cancer Ctr
SchoolSchool of Medicine
AddressLocation Required, #001
ORCID ORCID Icon0000-0003-2065-7846 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Perturbations in inflammatory pathways are associated with shortness of breath profiles in oncology patients receiving chemotherapy. Support Care Cancer. 2024 Mar 26; 32(4):250. Shin J, Miaskowski C, Wong ML, Yates P, Olshen AB, Roy R, Dokiparthi V, Cooper B, Paul S, Conley YP, Levine JD, Hammer MJ, Kober K. PMID: 38532105.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Torch-eCpG: a fast and scalable eQTM mapper for thousands of molecular phenotypes with graphical processing units. BMC Bioinformatics. 2024 Feb 14; 25(1):71. Kober KM, Berger L, Roy R, Olshen A. PMID: 38355413; PMCID: PMC10867984.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    3. Abstract B095: Leukemia inhibitory factor fosters tumor growth in KRAS-driven pancreatic ductal adenocarcinoma. Cancer Research. 2024 Jan 16; 84(2_Supplement):b095-b095. Miller-Phillips ML, Hanafi HI, Umetsu US, Olshen OA, Roy RR, Kiemen KA, Wang WM, Collisson CE. .
      View in: Publisher Site   Mentions:
    4. Analysis of DNA methylation at birth and in childhood reveals changes associated with season of birth and latitude. Clin Epigenetics. 2023 09 11; 15(1):148. Kadalayil L, Alam MZ, White CH, Ghantous A, Walton E, Gruzieva O, Merid SK, Kumar A, Roy RP, Solomon O, Huen K, Eskenazi B, Rzehak P, Grote V, Langhendries JP, Verduci E, Ferre N, Gruszfeld D, Gao L, Guan W, Zeng X, Schisterman EF, Dou JF, Bakulski KM, Feinberg JI, Soomro MH, Pesce G, Baiz N, Isaevska E, Plusquin M, Vafeiadi M, Roumeliotaki T, Langie SAS, Standaert A, Allard C, Perron P, Bouchard L, van Meel ER, Felix JF, Jaddoe VWV, Yousefi PD, Ramlau-Hansen CH, Relton CL, Tobi EW, Starling AP, Yang IV, Llambrich M, Santorelli G, Lepeule J, Salas LA, Bustamante M, Ewart SL, Zhang H, Karmaus W, Röder S, Zenclussen AC, Jin J, Nystad W, Page CM, Magnus M, Jima DD, Hoyo C, Maguire RL, Kvist T, Czamara D, Räikkönen K, Gong T, Ullemar V, Rifas-Shiman SL, Oken E, Almqvist C, Karlsson R, Lahti J, Murphy SK, Håberg SE, London S, Herberth G, Arshad H, Sunyer J, Grazuleviciene R, Dabelea D, Steegers-Theunissen RPM, Nohr EA, Sørensen TIA, Duijts L, Hivert MF, Nelen V, Popovic M, Kogevinas M, Nawrot TS, Herceg Z, Annesi-Maesano I, Fallin MD, Yeung E, Breton CV, Koletzko B, Holland N, Wiemels JL, Wiemels JL, Melén E, Sharp GC, Silver MJ, Rezwan FI, Holloway JW. PMID: 37697338; PMCID: PMC10496224.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    5. Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemia. Haematologica. 2023 05 01; 108(5):1272-1283. Pariury H, Fandel J, Bachl S, Ang KK, Markossian S, Wilson CG, Braun BS, Popescu B, Wohlfeil M, Beckman K, Xirenayi S, Roy RP, Olshen AB, Smith C, Arkin MR, Loh ML, Diaz-Flores E. PMID: 36700399; PMCID: PMC10153511.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    6. Prediction of morning fatigue severity in outpatients receiving chemotherapy: less may still be more. Support Care Cancer. 2023 Apr 11; 31(5):253. Kober KM, Roy R, Conley Y, Dhruva A, Hammer MJ, Levine J, Olshen A, Miaskowski C. PMID: 37039882.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Torch-eCpG: A fast and scalable eQTM mapper for thousands of molecular phenotypes with graphical processing units. bioRxiv. 2023 Mar 10. Kober KM, Berger L, Roy R, Olshen A. PMID: 36945384; PMCID: PMC10028892.
      View in: PubMed   Mentions:
    8. Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts. PLoS One. 2023; 18(3):e0282177. Lee RH, Roy R, Li H, Hechmer A, Zhu TR, Izgutdina A, Olshen AB, Johnson DE, Grandis JR. PMID: 36857322; PMCID: PMC9977000.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    9. Multiomic Single-Cell Sequencing of Mixed Phenotypic Acute Leukemia (MPAL) Reveals Complex Immunophenotypic, Transcriptional, and Genetic Heterogeneity. Blood. 2022 Nov 15; 140(Supplement 1):9146-9147. Peretz PC, Kennedy KV, Walia WA, Delley DC, Koh KA, Tran TE, Clark CI, Hayford HC, Xue XY, D'Amato DC, Fontanez FK, Roy RR, Olshen OA, Logan LA, Perl PA, Abate AA, Smith SC. .
      View in: Publisher Site   Mentions:
    10. A Transcriptional Classifier Identifies Pediatric T-Cell Acute Lymphoblastic Leukemias at High Risk for End of Induction Minimal Residual Disease. Blood. 2022 Nov 15; 140(Supplement 1):1722-1723. Meyer ML, Roy RR, Pölönen PP, Elsayed EA, Huang HB, Kimura KS, Delgado-Martin DC, Vincent VT, Ryan RT, Wood WB, Chen CZ, Liu LY, Zhang ZJ, Horton HT, Loh LM, Devidas DM, Raetz RE, Hayashi HR, Winter WS, Dunsmore DK, Hunger HS, Pounds PS, Hermiston HM, Yang YJ, Mullighan MC, Teachey TD, Olshen OA. .
      View in: Publisher Site   Mentions:
    11. 049 A TARGETED GENE EXPRESSION CLASSIFIER IDENTIFIES PEDIATRIC T-ALL PATIENTS AT HIGH RISK FOR END INDUCTION MINIMAL RESIDUAL DISEASE POSITIVITY. Leukemia Research. 2022 Oct 1; 121:s34-s35. Meyer ML, Roy RR, Huang HB, Kimura KS, Polonen PP, Delgado-Martin DC, Vincent VT, Ryan RT, Wood WB, Liu LY, Zhang ZJ, Mullighan MC, Horton HT, Loh LM, Devidas DM, Raetz RE, Hayashi HR, Winter WS, Dunsmore DK, Hunger HS, Teachey TD, Hermiston HM, Olshen OA. .
      View in: Publisher Site   Mentions:
    12. Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer. JCI Insight. 2021 10 22; 6(20). Bouhaddou M, Lee RH, Li H, Bhola NE, O'Keefe RA, Naser M, Zhu TR, Nwachuku K, Duvvuri U, Olshen AB, Roy R, Hechmer A, Bolen J, Keysar SB, Jimeno A, Mills GB, Vandenberg S, Swaney DL, Johnson DE, Krogan NJ, Grandis JR. PMID: 34546978; PMCID: PMC8564908.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    13. Targeted gene expression classifier identifies pediatric T-cell acute lymphoblastic leukemia (T-ALL) patients at high risk for end induction minimal residual disease positivity. Journal of Clinical Oncology. 2021 May 20; 39(15_suppl):10002-10002. Meyer ML, Roy RR, Huang HB, Delgado-Martin DC, Vincent VT, Wood WB, Liu LY, Zhang ZJ, Mullighan MC, Horton HT, Loh LM, Devidas DM, Raetz RE, Hayashi HR, Winter WS, Dunsmore DK, Hunger HS, Teachey TD, Olshen OA, Hermiston HM. .
      View in: Publisher Site   Mentions:
    14. Prediction of evening fatigue severity in outpatients receiving chemotherapy: less may be more. Fatigue. 2021; 9(1):14-32. Kober KM, Roy R, Dhruva A, Conley YP, Chan RJ, Cooper B, Olshen A, Miaskowski C. PMID: 34249477; PMCID: PMC8262130.
      View in: PubMed   Mentions: 3  
    15. Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or B-2-like based on a minimal transcriptional signature. Exp Hematol. 2020 10; 90:65-71.e1. Fitch B, Roy R, Geng H, Montecino-Rodriguez E, Bengtsson H, Gaillard C, Hiam K, Casero D, Olshen AB, Dorshkind K, Kogan SC. PMID: 32946981; PMCID: PMC7606616.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    16. Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes. J Clin Invest. 2020 02 03; 130(2):863-876. Meyer LK, Huang BJ, Delgado-Martin C, Roy RP, Hechmer A, Wandler AM, Vincent TL, Fortina P, Olshen AB, Wood BL, Horton TM, Shannon KM, Teachey DT, Hermiston ML. PMID: 31687977; PMCID: PMC6994137.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    17. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features. Ophthalmology. 2020 06; 127(6):804-813. Afshar AR, Pekmezci M, Bloomer MM, Cadenas NJ, Stevers M, Banerjee A, Roy R, Olshen AB, Van Ziffle J, Onodera C, Devine WP, Grenert JP, Bastian BC, Solomon DA, Damato BE. PMID: 32139107; PMCID: PMC7246167.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    18. The Genome-Wide Impact of Trisomy 21 on DNA Methylation and Its Implications for Hematologic Malignancies. Blood. 2019 Nov 13; 134(Supplement_1):2510-2510. Wiemels WJ, Muskens MI, Li LS, Pandey PP, Roy RR, Hansen HH, Siegmund SK, Mueller MB, Ma MX, Metayer MC, de Smith dA. .
      View in: Publisher Site   Mentions:
    19. Gene expression signature associated with in vitro dexamethasone resistance and post-induction minimal residual disease in pediatric T-cell acute lymphoblastic leukemia. Journal of Clinical Oncology. 2019 May 20; 37(15_suppl):10033-10033. Meyer ML, Delgado-Martin DC, Roy RR, Huang HB, Vincent VT, Olshen OA, Wood WB, Liu LY, Zhang ZJ, Mullighan MC, Horton HT, Loh LM, Devidas DM, Raetz RE, Hayashi HR, Winter WS, Dunsmore DK, Hunger HS, Teachey TD, Hermiston HM. .
      View in: Publisher Site   Mentions:
    20. Next-Generation Sequencing of Uveal Melanoma for Detection of Genetic Alterations Predicting Metastasis. Transl Vis Sci Technol. 2019 Mar; 8(2):18. Afshar AR, Damato BE, Stewart JM, Zablotska LB, Roy R, Olshen AB, Joseph NM, Bastian BC. PMID: 31024753; PMCID: PMC6472431.
      View in: PubMed   Mentions: 18     Fields:    
    21. Autocrine TGFβ Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment. Cancer Immunol Res. 2019 02; 7(2):306-320. Gonzalez-Junca A, Driscoll KE, Pellicciotta I, Du S, Lo CH, Roy R, Parry R, Tenvooren I, Marquez DM, Spitzer MH, Barcellos-Hoff MH. PMID: 30538091; PMCID: PMC6828175.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    22. Glucocorticoids Paradoxically Induce Intrinsic Steroid Resistance through a STAT5-Mediated Survival Mechanism in T-Cell Acute Lymphoblastic Leukemia. Blood. 2018 Nov 29; 132(Supplement 1):913-913. Meyer ML, Huang HB, Roy RR, Hechmer HA, Wandler WA, Delgado-Martin DC, Olshen OA, Horton HT, Teachey TD, Shannon SK, Hermiston HM. .
      View in: Publisher Site   Mentions:
    23. Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancer. NPJ Breast Cancer. 2018; 4:31. Magbanua MJM, Rugo HS, Hauranieh L, Roy R, Scott JH, Lee JC, Hsiao F, Sosa EV, Van't Veer L, Esserman LJ, Park JW. PMID: 30211312; PMCID: PMC6125436.
      View in: PubMed   Mentions: 16  
    24. Abstract 5578: Genomic and expression profiling reveals molecular heterogeneity of disseminated tumor cells in early breast cancer. Clinical Research (Excluding Clinical Trials). 2018 Jul 1; 5578-5578. Magbanua MM, Rugo RH, Hauranieh HL, Roy RR, Scott SJ, Lee LJ, Hsiao HF, Sosa SE, Wolf WD, Veer VL, Esserman EL, Park PJ. .
      View in: Publisher Site   Mentions:
    25. Replication confers β cell immaturity. Nat Commun. 2018 02 02; 9(1):485. Puri S, Roy N, Russ HA, Leonhardt L, French EK, Roy R, Bengtsson H, Scott DK, Stewart AF, Hebrok M. PMID: 29396395; PMCID: PMC5797102.
      View in: PubMed   Mentions: 76     Fields:    Translation:AnimalsCells
    26. Cohort Profile: Pregnancy And Childhood Epigenetics (PACE) Consortium. Int J Epidemiol. 2018 02 01; 47(1):22-23u. Felix JF, Joubert BR, Baccarelli AA, Sharp GC, Almqvist C, Annesi-Maesano I, Arshad H, Baïz N, Bakermans-Kranenburg MJ, Bakulski KM, Binder EB, Bouchard L, Breton CV, Brunekreef B, Brunst KJ, Burchard EG, Bustamante M, Chatzi L, Cheng Munthe-Kaas M, Corpeleijn E, Czamara D, Dabelea D, Davey Smith G, De Boever P, Duijts L, Dwyer T, Eng C, Eskenazi B, Everson TM, Falahi F, Fallin MD, Farchi S, Fernandez MF, Gao L, Gaunt TR, Ghantous A, Gillman MW, Gonseth S, Grote V, Gruzieva O, Håberg SE, Herceg Z, Hivert MF, Holland N, Holloway JW, Hoyo C, Hu D, Huang RC, Huen K, Järvelin MR, Jima DD, Just AC, Karagas MR, Karlsson R, Karmaus W, Kechris KJ, Kere J, Kogevinas M, Koletzko B, Koppelman GH, Küpers LK, Ladd-Acosta C, Lahti J, Lambrechts N, Langie SAS, Lie RT, Liu AH, Magnus MC, Magnus P, Maguire RL, Marsit CJ, McArdle W, Melén E, Melton P, Murphy SK, Nawrot TS, Nisticò L, Nohr EA, Nordlund B, Nystad W, Oh SS, Oken E, Page CM, Perron P, Pershagen G, Pizzi C, Plusquin M, Raikkonen K, Reese SE, Reischl E, Richiardi L, Ring S, Roy RP, Rzehak P, Schoeters G, Schwartz DA, Sebert S, Snieder H, Sørensen TIA, Starling AP, Sunyer J, Taylor JA, Tiemeier H, Ullemar V, Vafeiadi M, Van Ijzendoorn MH, Vonk JM, Vriens A, Vrijheid M, Wang P, Wiemels JL, Wiemels JL, Wilcox AJ, Wright RJ, Xu CJ, Xu Z, Yang IV, Yousefi P, Zhang H, Zhang W, Zhao S, Agha G, Relton CL, Jaddoe VWV, London SJ. PMID: 29025028; PMCID: PMC5837319.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCellsPHPublic Health
    27. Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance). Clin Cancer Res. 2018 03 15; 24(6):1486-1499. Magbanua MJM, Rugo HS, Wolf DM, Hauranieh L, Roy R, Pendyala P, Sosa EV, Scott JH, Lee JS, Pitcher B, Hyslop T, Barry WT, Isakoff SJ, Dickler M, Van't Veer L, Park JW. PMID: 29311117; PMCID: PMC5856614.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    28. Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor. Transl Oncol. 2017 Dec; 10(6):895-903. Autry A, Phillips JJ, Maleschlijski S, Roy R, Molinaro AM, Chang SM, Cha S, Lupo JM, Nelson SJ. PMID: 28942218; PMCID: PMC5612804.
      View in: PubMed   Mentions: 9  
    29. Association of early changes in 1H MRSI parameters with survival for patients with newly diagnosed glioblastoma receiving a multimodality treatment regimen. Neuro Oncol. 2017 03 01; 19(3):430-439. Nelson SJ, Kadambi AK, Park I, Li Y, Crane J, Olson M, Molinaro A, Roy R, Butowski N, Cha S, Chang S. PMID: 27576874; PMCID: PMC5464305.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    30. Correlates of Prenatal and Early-Life Tobacco Smoke Exposure and Frequency of Common Gene Deletions in Childhood Acute Lymphoblastic Leukemia. Cancer Res. 2017 04 01; 77(7):1674-1683. de Smith AJ, Kaur M, Gonseth S, Endicott A, Selvin S, Zhang L, Roy R, Shao X, Hansen HM, Kang AY, Walsh KM, Dahl GV, McKean-Cowdin R, Metayer C, Wiemels JL, Wiemels JL. PMID: 28202519; PMCID: PMC5380517.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsPHPublic Health
    31. Abstract P1-01-04: Comprehensive genomic characterization of circulating tumor cells (CTCs) in metastatic breast cancer (MBC) sheds light on the biology of blood-borne metastasis. Poster Session Abstracts. 2017 Feb 15; p1-01-04-p1-01-04. Magbanua MM, Hauranieh HL, Roy RR, Wolf WD, Benz BS, Vaske VC, Pendyala PP, Sosa SE, Scott SJ, Lee LJ, Ordonez OA, Ho HB, Solanki ST, VantVeer VL, Rugo RH, Park PJ. .
      View in: Publisher Site   Mentions:
    32. Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival. Clin Epigenetics. 2017; 9:10. Wiencke JK, Koestler DC, Salas LA, Wiemels JL, Wiemels JL, Roy RP, Hansen HM, Rice T, McCoy LS, Bracci PM, Molinaro AM, Kelsey KT, Wrensch MR, Christensen BC. PMID: 28184256; PMCID: PMC5288996.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    33. Genetic Subtypes of Human Pediatric ALLs Show Gene Expression Differences That Parallel Those Observed in Mouse B1 and B2 Progenitors, Suggesting Divergent Developmental Origins. Blood. 2016 Dec 2; 128(22):1741-1741. Kogan KS, Geng GH, Roy RR, Montecino-Rodriguez ME, Gaillard GC, Hiam HK, Bengtsson BH, Casero CD, Olshen OA, Dorshkind DK. .
      View in: Publisher Site   Mentions:
    34. GENT-13. IMMUNOMETHYLOMIC ASSAY OF BLOOD NEUTROPHIL LYMPHOCYTE RATIO (NLR) IN GLIOMA SURVIVAL. Neuro-Oncology. 2016 Nov 1; 18(suppl_6):vi76-vi76. Wiencke WJ, Koestler KD, Molinaro MA, Wiemels WJ, Roy RR, Hansen HH, Rice RT, Bracci BP, McCoy ML, Kelsey KK, Wrensch WM, Christensen CB. .
      View in: Publisher Site   Mentions:
    35. Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab. J Neurooncol. 2016 10; 130(1):171-179. Nelson SJ, Li Y, Lupo JM, Olson M, Crane JC, Molinaro A, Roy R, Clarke J, Butowski N, Prados M, Cha S, Chang SM. PMID: 27535746; PMCID: PMC5069332.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    36. Genetic contribution to variation in DNA methylation at maternal smoking-sensitive loci in exposed neonates. Epigenetics. 2016 09; 11(9):664-673. Gonseth S, de Smith AJ, Roy R, Zhou M, Lee ST, Shao X, Ohja J, Wrensch MR, Walsh KM, Metayer C, Wiemels JL, Wiemels JL. PMID: 27403598; PMCID: PMC5048731.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    37. An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer. Cancer Lett. 2016 09 28; 380(1):144-52. Premasekharan G, Gilbert E, Okimoto RA, Hamirani A, Lindquist KJ, Ngo VT, Roy R, Hough J, Edwards M, Paz R, Foye A, Sood R, Copren KA, Gubens M, Small EJ, Bivona TG, Collisson EA, Friedlander TW, Paris PL. PMID: 27343980.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    38. Genomic profiling to distinguish poorly differentiated neuroendocrine carcinomas arising in different sites. Journal of Clinical Oncology. 2016 May 20; 34(15_suppl):4020-4020. Bergsland BE, Roy RR, Stephens SP, Ross RJ, Bailey BM, Olshen OA. .
      View in: Publisher Site   Mentions:
    39. Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials. Transl Oncol. 2015 Dec; 8(6):446-55. Wen Q, Jalilian L, Lupo JM, Li Y, Roy R, Molinaro AM, Chang SM, Prados M, Butowski N, Clarke J, Nelson SJ. PMID: 26692525; PMCID: PMC4700297.
      View in: PubMed   Mentions: 1  
    40. Associations between circulating carotenoids, genomic instability and the risk of high-grade prostate cancer. Prostate. 2016 Mar; 76(4):339-48. Nordström T, Van Blarigan EL, Ngo V, Roy R, Weinberg V, Song X, Simko J, Carroll PR, Chan JM, Paris PL. PMID: 26585352; PMCID: PMC5493324.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    41. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Nat Genet. 2015 Oct; 47(10):1194-9. Shain AH, Garrido M, Botton T, Talevich E, Yeh I, Sanborn JZ, Chung J, Wang NJ, Kakavand H, Mann GJ, Thompson JF, Wiesner T, Roy R, Olshen AB, Gagnon A, Gray JW, Huh N, Hur JS, Busam KJ, Scolyer RA, Cho RJ, Murali R, Bastian BC. PMID: 26343386; PMCID: PMC4589486.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansCells
    42. Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation. Haematologica. 2015 Aug; 100(8):1064-75. Gaillard C, Tokuyasu TA, Rosen G, Sotzen J, Vitaliano-Prunier A, Roy R, Passegué E, de Thé H, Figueroa ME, Kogan SC. PMID: 26088929; PMCID: PMC5004423.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    43. Epigenetic remodeling in B-cell acute lymphoblastic leukemia occurs in two tracks and employs embryonic stem cell-like signatures. Nucleic Acids Res. 2015 Mar 11; 43(5):2590-602. Lee ST, Muench MO, Fomin ME, Xiao J, Zhou M, de Smith A, Martín-Subero JI, Heath S, Houseman EA, Roy R, Wrensch M, Wiencke J, Metayer C, Wiemels JL, Wiemels JL. PMID: 25690899; PMCID: PMC4357708.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    44. Periconceptional folate consumption is associated with neonatal DNA methylation modifications in neural crest regulatory and cancer development genes. Epigenetics. 2015; 10(12):1166-76. Gonseth S, Roy R, Houseman EA, de Smith AJ, Zhou M, Lee ST, Nusslé S, Singer AW, Wrensch MR, Metayer C, Wiemels JL, Wiemels JL. PMID: 26646725; PMCID: PMC4844202.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    45. Two-Track Epigenetic Remodeling and Backtracking to Embryonic Stem Cell Bivalency in B-Cell Acute Lymphoblastic Leukemias. Blood. 2014 Dec 6; 124(21):3557-3557. Lee LS, Muench MM, Fomin FM, Xiao XJ, Zhou ZM, de Smith dA, Martín-Subero MJ, Heath HS, Houseman HE, Roy RR, Wrensch WM, Wiencke WJ, Metayer MC, Wiemels WJ. .
      View in: Publisher Site   Mentions:
    46. Genetic variants of Adam17 differentially regulate TGFβ signaling to modify vascular pathology in mice and humans. Proc Natl Acad Sci U S A. 2014 May 27; 111(21):7723-8. Kawasaki K, Freimuth J, Meyer DS, Lee MM, Tochimoto-Okamoto A, Benzinou M, Clermont FF, Wu G, Roy R, Letteboer TG, Ploos van Amstel JK, Giraud S, Dupuis-Girod S, Lesca G, Westermann CJ, Coffey RJ, Akhurst RJ. PMID: 24812125; PMCID: PMC4040598.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    47. Genome-wide copy number analysis of cerebrospinal fluid tumor cells and their corresponding archival primary tumors. Genom Data. 2014 Dec; 2:60-2. Magbanua MJ, Roy R, Sosa EV, Hauranieh L, Kablanian A, Eisenbud LE, Ryazantsev A, Au A, Scott JH, Melisko M, Park JW. PMID: 26484071; PMCID: PMC4535622.
      View in: PubMed   Mentions: 6  
    48. PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemia. Int J Cancer. 2014 Sep 01; 135(5):1101-9. Xiao J, Lee ST, Xiao Y, Ma X, Houseman EA, Hsu LI, Roy R, Wrensch M, de Smith AJ, Chokkalingam A, Buffler P, Wiencke JK, Wiemels JL, Wiemels JL. PMID: 24496747; PMCID: PMC4776754.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    49. Molecular profiling of tumor cells in cerebrospinal fluid and matched primary tumors from metastatic breast cancer patients with leptomeningeal carcinomatosis. Cancer Res. 2013 Dec 01; 73(23):7134-43. Magbanua MJ, Melisko M, Roy R, Sosa EV, Hauranieh L, Kablanian A, Eisenbud LE, Ryazantsev A, Au A, Scott JH, Park JW. PMID: 24142343.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    50. Detection and genomic interrogation of invasive circulating tumor cells (iCTCs) derived from men with metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 2013 May 20; 31(15_suppl):11048-11048. Friedlander FT, Weinberg WV, Roy RR, Ngo NV, Dong DH, Doty DS, Zhao ZQ, Premasekharan PG, Gilbert GE, Ryan RC, Chen CW, Paris PP. .
      View in: Publisher Site   Mentions:
    51. Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients. Cancer Res. 2013 Jan 01; 73(1):30-40. Magbanua MJ, Sosa EV, Roy R, Eisenbud LE, Scott JH, Olshen A, Pinkel D, Rugo HS, Park JW. PMID: 23135909; PMCID: PMC4085329.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    52. Diversity of antigen-specific responses induced in vivo with CTLA-4 blockade in prostate cancer patients. J Immunol. 2012 Oct 01; 189(7):3759-66. Kwek SS, Dao V, Roy R, Hou Y, Alajajian D, Simko JP, Small EJ, Fong L. PMID: 22956585; PMCID: PMC3448828.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    53. Regulators of skeletal development: a cluster analysis of 206 bone tumors reveals diagnostically useful markers. Mod Pathol. 2012 Nov; 25(11):1452-61. Horvai AE, Roy R, Borys D, O'Donnell RJ. PMID: 22766796.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    54. Abstract 5079: A genomic copy number biomarker to identify oral cancer patients at low risk for metastasis. Molecular and Cellular Biology. 2012 Apr 15; 5079-5079. Bhattacharya BA, Snijders SA, Roy RR, Hamilton HG, Paquette PJ, Tokuyasu TT, Bengtsson BH, Jordan JR, Olshen OA, Pinkel PD, Schmidt SB, Albertson AD. .
      View in: Publisher Site   Mentions:
    55. Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia. Nat Commun. 2012 Jan 10; 3:616. Benzinou M, Clermont FF, Letteboer TG, Kim JH, Espejel S, Harradine KA, Arbelaez J, Luu MT, Roy R, Quigley D, Higgins MN, Zaid M, Aouizerat BE, van Amstel JK, Giraud S, Dupuis-Girod S, Lesca G, Plauchu H, Hughes CC, Westermann CJ, Akhurst RJ. PMID: 22233626; PMCID: PMC3509798.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimals
    56. Erratum: Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia. Nature Communications. 2012 Jan 1; 3(1):1148. Benzinou BM, Clermont CF, Letteboer LT, Kim KJ, Espejel ES, Harradine HK, Arbelaez AJ, Luu LM, Roy RR, Quigley QD, Higgins HM, Zaid ZM, Aouizerat AB, van Amstel vJ, Giraud GS, Dupuis-Girod DS, Lesca LG, Plauchu PH, Hughes HC, Westermann WC, Akhurst AR. .
      View in: Publisher Site   Mentions:
    57. P1-06-09: Patient-Specific Integrative Pathway Analysis Using PARADIGM Identifies Key Activities in I-SPY 1 Breast Cancer Patients (CALGB 150007/150012; ACRIN 6657). Poster Session Abstracts. 2011 Dec 15; p1-06-09-p1-06-09. Wolf WD, Yau YC, Benz BS, Vaske VC, Stuart SJ, Roy RR, Olshen OA, Boudreau BA, Haussler HD, Gray GJ, Spellman SP, Davis DS, Hylton HN, Van Veer VL, Esserman EL. .
      View in: Publisher Site   Mentions:
    58. Common structural and epigenetic changes in the genome of castration-resistant prostate cancer. Cancer Res. 2012 Feb 01; 72(3):616-25. Friedlander TW, Roy R, Tomlins SA, Ngo VT, Kobayashi Y, Azameera A, Rubin MA, Pienta KJ, Chinnaiyan A, Ittmann MM, Ryan CJ, Paris PL. PMID: 22158653.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    59. Abstract A69: Subtype-specific targeting of RAS signal transduction in pancreatic ductal adenocarcinoma. Cellular Responses to Therapy. 2011 Nov 12; a69-a69. Mirzoeva MO, Collisson CE, Schaefer SP, Roy RR, Korn KW. .
      View in: Publisher Site   Mentions:
    60. Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis. Clin Cancer Res. 2011 Nov 15; 17(22):7024-34. Bhattacharya A, Roy R, Snijders AM, Hamilton G, Paquette J, Tokuyasu T, Bengtsson H, Jordan RC, Olshen AB, Pinkel D, Schmidt BL, Albertson DG. PMID: 22068658; PMCID: PMC3226754.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    61. Genome-wide copy number analysis of circulating tumor cells from patients (pts) with metastatic breast cancer (MBC). Journal of Clinical Oncology. 2011 Sep 20; 29(27_suppl):9-9. Magbanua MM, Sosa SE, Roy RR, Eisenbud EL, Scott SJ, Olshen OA, Pinkel PD, Rugo RH, Park PJ. .
      View in: Publisher Site   Mentions:
    62. Gene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementation. PLoS One. 2011; 6(9):e24004. Magbanua MJ, Roy R, Sosa EV, Weinberg V, Federman S, Mattie MD, Hughes-Fulford M, Simko J, Shinohara K, Haqq CM, Carroll PR, Chan JM. PMID: 21912659; PMCID: PMC3164676.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    63. Genomic alterations and phenotype of large compared to small high-grade ductal carcinoma in situ. Hum Pathol. 2011 Oct; 42(10):1467-75. Hwang ES, Lal A, Chen YY, DeVries S, Swain R, Anderson J, Roy R, Waldman FM. PMID: 21496874.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    64. Identification of gene copy number and whole-genome methylation changes associated with lethal metastatic castration-resistant prostate cancer (CRPC). Journal of Clinical Oncology. 2011 Mar 1; 29(7_suppl):6-6. Friedlander FT, Roy RR, Tomlins TS, Kobayashi KY, Rubin RM, Pienta PK, Chinnaiyan CA, Small SE, Ryan RC, Paris PP. .
      View in: Publisher Site   Mentions:
    65. Genetic and morphologic features for melanoma classification. Pigment Cell Melanoma Res. 2010 Dec; 23(6):763-70. Broekaert SM, Roy R, Okamoto I, van den Oord J, Bauer J, Garbe C, Barnhill RL, Busam KJ, Cochran AJ, Cook MG, Elder DE, McCarthy SW, Mihm MC, Schadendorf D, Scolyer RA, Spatz A, Bastian BC. PMID: 20874733; PMCID: PMC3107973.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    66. Identification of novel prostate cancer-associated antigens through antibody profiling of prostate cancer patients treated with CTLA-4 blockade. Journal of Clinical Oncology. 2010 May 20; 28(15_suppl):2578-2578. Fong FL, Kwek KS, Dao DV, Roy RR, Hou HY, Simko SJ, Small SE. .
      View in: Publisher Site   Mentions:
    67. Abstract 2137: Association of copy number aberrations with oral cancer metastasis and progression of pre-malignant oral lesions. Cellular and Molecular Biology. 2010 Apr 15; 2137-2137. Bhattachayra BA, Snijders SA, Roy RR, Tokuyasu TT, Jordan JR, Olshen OA, Pinkel PD, Schmidt SB, Albertson AD. .
      View in: Publisher Site   Mentions:
    68. A group of genome-based biomarkers that add to a Kattan nomogram for predicting progression in men with high-risk prostate cancer. Clin Cancer Res. 2010 Jan 01; 16(1):195-202. Paris PL, Weinberg V, Albo G, Roy R, Burke C, Simko J, Carroll P, Collins C. PMID: 20028763; PMCID: PMC2854027.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    69. Loss of Blm enhances basal cell carcinoma and rhabdomyosarcoma tumorigenesis in Ptch1+/- mice. Carcinogenesis. 2010 Jun; 31(6):968-73. Davari P, Hebert JL, Albertson DG, Huey B, Roy R, Mancianti ML, Horvai AE, McDaniel LD, Schultz RA, Epstein EH. PMID: 19995795; PMCID: PMC2878356.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    70. Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol. 2009 Nov; 33(11):1683-94. Chen YY, Hwang ES, Roy R, DeVries S, Anderson J, Wa C, Fitzgibbons PL, Jacobs TW, MacGrogan G, Peterse H, Vincent-Salomon A, Tokuyasu T, Schnitt SJ, Waldman FM. PMID: 19701073; PMCID: PMC2783988.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    71. Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma. Mod Pathol. 2009 Nov; 22(11):1477-88. Horvai AE, DeVries S, Roy R, O'Donnell RJ, Waldman F. PMID: 19734852.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    72. Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer. Hepatology. 2008 Apr; 47(4):1200-10. Lee SA, Ho C, Roy R, Kosinski C, Patil MA, Tward AD, Fridlyand J, Chen X. PMID: 18214995.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimals
    73. Evaluation of whole genome amplification protocols for array and oligonucleotide CGH. Diagn Mol Pathol. 2007 Dec; 16(4):198-206. Hittelman A, Sridharan S, Roy R, Fridlyand J, Loda M, Collins C, Paris PL. PMID: 18043282.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans